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Hot*spot mutations in the p53 gene of liver nodules
induced in rats fed DL*ethionine with a methyl*deficient
diet
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Summary Male F-344 rats were fed for 15 weeks a methyl-deficient L-amino acid defined diet containing 0.05% DL-ethionine. Nodules
protruding from the surface of the liver were dissected free of surrounding tissue, and polyadenylated RNA isolated from the nodules was
reverse transcribed. The region of the p53 gene comprising codons 120-290 was amplified by the polymerase chain reaction, and cDNAs
were sequenced. Mutations were detected in nodules obtained from 7 of 12 rats. In all seven cases, the same two point mutations were
present. The first was at the first base of codon 246 and consisted of a C-*T transition (C:G--T:A, Arg-*Cys), while the second was at the
second base of codon 247 and consisted of a G-*T transversion (G:C->T:A, Arg->Leu). It is concluded that the hepatocarcinogen ethionine
induces specific hot-spot p53 gene mutations; this is in contrast to the mutations at various sites previously observed to occur in rats fed a
hepatocarcinogenic methyl-deficient diet alone. The results also provide the first evidence that ethionine is mutagenic in the rat.
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In a previous study (Smith et al, 1993), a high frequency ofp53
gene mutations was detected in hepatocellular carcinomas (HCCs)
induced in rats fed a methyl-deficient diet. No hot-spot codon was
observed as the mutations were present at various sites ofthe gene
and were unique in each tumour. The findings were therefore
consistent with the lack of evidence that, during treatment, the
animals were exposed to chemical carcinogen contaminants in
theirtotal environment (Lombardi and Smith, 1994). In addition to
being hepatocarcinogenic per se, methyl-deficient diets also act
as strong co-carcinogens of hepatocarcinogenesis by chemical
carcinogens (Newberne, 1986; Shinozuka et al, 1986), including
ethionine (Shinozuka et al, 1978; Leopold et al, 1982; Tsujiuchi et
al, 1995). This chemical hepatocarcinogen is of singular interest
because, when fed to rats, it decreases the availability of methyl
groups for transmethylation reactions, including methylation of
nucleic acids, as in the case of methyl-deficient diets (Farber,
1963; Ghoshal et al, 1986; Poirier, 1986; Christman et al, 1993).
This effect of ethionine stems from the fact that it blocks the
sulphur activation of methionine, leading to depletion of the
primary donor of methyl groups, S-adenosylmethionine, and to
formation instead of S-adenosylethionine, a transethylating agent.
There is, in fact, some indication in the literature that ethionine
may lead to ethylation of rat liver DNA (Swann et al, 1971; Cox
and Farber, 1972). Ifthis is indeed the case, abnormalities in DNA
methylation could be a result shared by both methyl-deficient diets
and ethionine, while DNA ethylation could be the effect that
differentiates the hepatocarcinogenicity of ethionine from that of
methyl-deficient diets. For this reason, it was deemed ofinterest to
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determine whether inclusion ofethionine in a methyl-deficient diet
would result in p53 gene mutations and whether their pattern
would be different from that previously observed in rats fed a
methyl-deficient diet alone (Smith et al, 1993).
MATERIALS AND METHODS
Thirty-four 5-week-old male F-344 rats (Harlan Sprague-Dawley,
Indianapolis, IN, USA) were housed in stainless-steel wire cages
in an air-conditioned atmosphere with constant temperature
(22 ± 2°C) and humidity (50 ± 10%) and under a 12-h dark-light
cycle. Besides a laboratory chow (Wayne Rodent Blocks, Wayne
Pet Food Division, Continental Grain Company, Chicago, IL,
USA), three semisynthetic diets were used: a methyl-deficient
(CDAA) diet, a CDAA diet containing 0.05% DL-ethionine at the
expense ofsucrose (CDAAE diet) and a CDAA diet supplemented
with choline (CSAA diet). The CDAA and CSAA diets had the
same overall composition as the semipurified choline-deficient
and choline-supplemented diets used in previous studies
(Shinozuka et al, 1978; Smith et al, 1993), except that proteins
were replaced with an equivalent and corresponding mixture of
L-amino acids. They were chosen because the CDAA diet has
greater and more rapid effects on rat liver than the semipurified
choline-deficient diet (Nakae et al, 1990, 1992, 1994; Tsujiuchi
et al, 1995). The diets were purchased in pellet form from Dyets,
Bethlehem, PA, USA.
The rats were acclimatized for 1 week on laboratory chow
before being fed the experimental diets. In consideration of a
possible high mortality, 22 rats were placed on the CDAAE diet
(CDAAE rats) and six each were placed on the CDAA and CSAA
diets (CDAA rats and CSAA rats respectively). The initial body
weight of the rats was 101 ± 7 g (mean ± s.d.). Feed and water
were offered ad libitum throughout, and the animals were weighed
weekly and at the time ofsacrifice.
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Table 1 Oligonucleotide primers used
Primer (5' to 3') Starting/ending Starting/ending Remarks
Codon no. +Base no.
GGGACAGCCAAGTCTGTTATG 115/121 343/363 External, sense and PCR
TTTCCCTCAATAAGCTGTTC 126/132 377/396 Internal, sense, PCR and sequencing
CTATACCACTATCCACATAC 226/232 678/696 Internal, sense, PCR and sequencing
AGAGGAGCTTGTGCTGGT 308/313 924/939 External, antisense and PCR
TCTCCCAGGACAGGCA 273/278 819/834 Internal, antisense, PCR and sequencing
GGCTCATACGGTACCACCAC 214/220 642/659 Internal, antisense and PCR
GTGGGAATCTTCTGGGAC 259/265 776/793 Internal, sense and sequencing only
At necropsy, the liver of each rat was quickly removed and
weighed, and its appearance was noted. Nodules grossly visible on
the organ surface of CDAAE and CDAA rats were rapidly
dissected from surrounding tissue, immediately frozen in liquid
nitrogen and stored at -80°C until further processing for RNA
isolation. Liver blocks from CSAA rats were similarly frozen and
stored for that purpose. Histological examination of the isolated
nodules was not performed because of their small size (see
Results) and the need to obtain from them amounts of RNA suffi-
cient for the planned analyses. On the other hand, 5-mm-thick
slices ofthe harvested livers and ofCSAA rat livers were fixed in
10% buffered formalin, embedded in paraffin, and 5-pm-thick
sections were routinely stained with haematoxylin-eosin.
Total RNA was isolated from the frozen nodules collected from
CDAAE and CDAA rats, from frozen samples ofCSAA rat livers
and from liver samples of rats fed only laboratory chow. The
RNAzol procedure was used as indicated by the manufacturer
(Tel-Test, Friendswood, TX, USA), and the purity of the isolated
RNA was verified by electrophoresis on a 0.8% formaldehyde gel
(Sambrook et al, 1989). Poly(A)+RNA was isolated using oligo-
dT-cellulose (Sambrook et al, 1989), and its purity was also veri-
fied by electrophoresis on the formaldehyde gel. About 1 gg of
Poly(A)+RNA was then reverse transcribed into first-strand
cDNAs using 100 pmol random hexamer primers (Kawasaki and
Wang, 1989; Harvey and Levine, 1991; Pharmacia, Piscataway,
NJ, USA), 1 mm deoxynucleotide triphosphates (Boehringer-
Mannheim, Indianapolis, IN, USA) and 200 units of MMLV
reverse transcriptase (United States Biochemicals, Cleveland, OH,
USA) under the conditions recommended by the manufacturer.
For second-strand synthesis by polymerase chain reaction (PCR),
5 ,ul of heat-treated reverse-transcriptase (RT) reaction mixture
was amplified in 10 mm Tris-HCl pH 8.3, 50 mm potassium chlo-
ride, 2 mm magnesium chloride, 1% formamide, 0.1 mM tetram-
ethylammonium chloride, 0.2 mM deoxynucleotide triphosphates,
2 units of Amplitaq DNA polymerase (Pertkin-Elmer/Cetus,
Norwalk, CT, USA) and 100 ng each of 'upstream' (sense) and
'downstream' (antisense) primers. The primers (Stratagene, La
Jolla, CA, USA, or Genosys, Houston, TX, USA) shown in
Table 1, based on the sequence of a rat p53 cDNA (Soussi et al,
1988), were used as indicated. The primers spanned thep53 cDNA
gene codon regions 120-290 (exons 5-8), which include the
highly conserved domains of the gene and are the sites at which
mutations in human and experimental liver tumours have been
most frequently detected (Hollstein et al, 1991; Smith et al, 1993;
Vancutsem et al, 1994). A 'double'-nested PCR strategy was used,
whereby an initial amplification, using external primers, was
diluted 50-fold into a new PCR reaction mix and amplified using a
set of internal primers. Following an initial 'hot start' at 95°C
for 1 min, annealing at 40-450C for 1 min and extending at 72°C
for 1 min were used in all cases. The products were visualized on a
2% low-melt agarose gel (FMC Bioproducts, Rockland, ME,
USA) stained with ethidium bromide, and the bands were cut out
and purified using 'Magic' columns (Promega, Madison, WI,
USA). The purified products were then sequenced using Taq-
polymerase-based 'fmol' sequencing kits (Promega), according to
manufacturer protocols, using [S35]dATP (New England Nuclear,
Boston, MA, USA). Negative PCR controls consisted of omis-
sions of RT or of cDNA template, and positive controls consisted
of Poly(A)+RNA isolated from two HCCs with knownp53 muta-
tions (Smith et al, 1993).
The purified PCR products were also used for digestion with the
restriction endonucleases Acil and Nael (New England Biolabs,
Beverly, MA, USA), whichcleave the nucleotide sequence 5'..C/C-
G-C/C-G-G/C..3' at the first C-C (Acil) and (Nael) second C-G
(Polisson and Morgan, 1990; New England Biolabs, 1993/1994).
Approximately 1 ,ug ofproduct was digested with 5-10 units ofthe
enzymes for 3 h at 37°C and was subjected to electrophoresis on
12% acrylamide gels (Sambrook et al, 1989). Single-strand confor-
mation polymorphism (SSCP) analyses were performed as indi-
cated (Orita et al, 1989) using [32P]dATP or [32P]dCTPduring PCR;
the PCR products were diluted, denatured by heating in formamide
buffer, electrophoresed in 10% non-denaturing polyacrylamide
gels, dried and exposed to radiographic film.
RESULTS
The duration ofthe experiment was 15 weeks. Three CDAAE rats
died after 9-13 weeks, while seven were killed at various time
intervals for exploratory purposes. These rats were not included in
the study. No mortality occurred among the CDAA and CSAA
rats, and the study was therefore conducted on 12 CDAAE rats, six
CDAA rats and six CSAA rats.
CDAAE rats exhibited no growth throughout the experimental
period. The final body weights were 96± 3, 307 ± 5 and 373 ± 11
(g, mean ± s.e.) in CDAAE, CDAA and CSAA rats respectively;
liver weights (g per 100 g body weight) were 5.4 ± 0.3, 4.8 ± 0.1
and 3.3 ± 0.1 respectively. On gross inspection, a very high degree
of nodularity involving every lobe of the liver was present in all
CDAAE rats killed at the end of the experiment. The nodules,
whitish in colour, protruded clearly from the surface and had a
diameter ranging from 2 to 8 mm. The livers of CDAA rats were
somewhat enlarged, yellowish in colour and had a comparatively
smooth surface; however, each showed on the surface two to five
nodules, 1-3 mm in diameter. The livers ofCSAA rats were unre-
markable. On histopathological examination, a marked atrophy of
the liver parenchyma, an intense and diffuse proliferation of oval
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Figure 3 Representative DNA sequence analyses of wild-type and mutant
p53cDNAs, prepared from the liver of a rat fed the control CSAA diet (WT),
and a single 8-mm-diameter protruding nodule in a rat fed the CDAAE diet
(MUT). Both antisense (A) and sense (B) strands were sequenced
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Figure 1 Low (40x) magnification view of a preneoplastic nodule embedded
in the liver of a rat fed the CDAAE diet. H and E-stained section
4_
Figure 2 High (1OOx) magnification view of a preneoplastic nodule
embedded in the liver of a rat fed the CDAAE diet. H and E stained section
and duct(ular) cells and areas of cholangiofibrosis were the most
prominent alterations in CDAAE rats; additionally, foci of altered
hepatocytes (AHFs) and preneoplastic nodules (PNNs, Figures 1
and 2) were present. In CDAA rats, a diffuse steatosis, AHFs and
an occasional PNN were the most salient lesions noted. The livers
of CSAA rats were also unremarkable upon histopathological
examination. The above findings were all consistent with results
previously described in detail (Farber, 1963; Shinozuka et al,
1978; Leopold et al, 1982; Tsujiuchi et al, 1995).
DNA sequencing was performed on exon 5-8 cDNAs derived
from nodule samples ofsix CDAAE rats. The samples consisted of
a single 8-mm-diameter nodule and of pools of 3-5 smaller, but
among the larger, nodules removed from five other individual rats.
No deviations from the sequence ofwild-typep53 were detected in
exons 5, 6 and 8. All samples, however, contained two point muta-
tions, which were the same in each sample, in exon 7. As illus-
trated in Figure 3, the site of the first mutation was the first base
of codon 246 and consisted of a C -> T transition (C:G-4T:A,
Arg-Cys), while the second mutation was at the second base of
codon 247 and consisted of a G-+T transversion (G:C-4T:A,
Arg -> Leu). Interestingly, the single nodule analysed contained
both mutations. Identical results were obtained from duplicate
analyses of the same and of new PCR products, and sequencing of
Figure 4 Restriction digests of exon 7 cDNAs (159 bp) with the Acil (A) or
Nael (B) endonucleases. Wild-type p53 sequences are completely cleaved
(lanes 1), while mutant alleles are resistant to cleavage by either enzyme
(lanes 2-7). U, non-restricted PCR products; lanes 3, mutated p53
sequences from a single 8-mm-diameter nodule. In C, sequences from the
latter nodule were digested with Acil (lane 1), Nael (lane 2) or with both
endonucleases (lane 3). Note that the mutant PCR product was completely
cleaved when both enzymes were used together, indicating that one
mutation is present in each allele. (Acil yields two fragments of 99 and 60 bp
and Nael yields two of 96 and 63 bp. The differences between 99 and 96 bp
and between 60 and 63 bp are too small to be resolved.) If both mutations
were present in one and the same allele, the mutant allele would have been
resistant to cleavage by the restriction-enzyme combination
the cDNAs in both directions yielded consistent results (Figure 3).
By sequencing, the genotype of the mutations appeared to be
heterozygous (Figure 3). Codons 246 and 247 in exon 7 ofthep53
gene represent a unique base sequence (5'..C/C-G-C/C-G-G/C..3')
for which restriction enzymes are available; heterozygosity of
the mutations was also shown by cleaving exon 7 cDNAs (codons
226-278) with the Acil or Nael restriction endonucleases
(Figure 4). Homozygosity, however, could have been masked by
the presence in the nodules of normal stromal and biliary oval
cells. To test whether the two mutations were present in the same
allele, or one in each allele, exon 7 cDNAs were digested with
both endonucleases simultaneously. The results indicated that one
mutation was present in each allele (Figure 4).
SSCP analyses of exon 7 cDNAs also revealed the presence of
mutation(s) in six samples of nodules, as shown in Figure 5A,
lanes 2-7. For this reason, SSCP analyses were next performed on
exon 7 cDNAs prepared from pools of nodules obtained individu-
ally from the other six CDAAE rats. These pools were larger and
consisted of even smaller nodules. Mutation(s) were detected in
only one ofthese pools, and sequencing analysis revealed the pres-
ence ofthe same two point mutations, at codons 246 and 247, seen
in the previous samples (data not shown but see lane 8 in Figure
5A). The observed mutation frequency, therefore, was 58% (7 out
of 12 rats).
SSCP analyses of exon 7 cDNAs derived from six individual
pools, each consisting of nodules obtained from a single CDAA
rat, were then performed. The analyses revealed the presence of a
mutation(s) in three of the six pools (see Figure 5B, lanes 3, 5 and
7); sequence analyses showed no deviation from the wild-type
sequence in three pools and the presence of a single but different
point mutation in the probative three: a G-*A transition
(C:G-*C:A, Arg->Gln) at the second base of codon 265; a T-*C
British Journal ofCancer (1997) 76(1), 15-20
_-159
-99196
- 60/63
0Cancer Research Campaign 199718 T Tsujiuchi etal
B
U 1 2 3 4 5 6 7
Figure 5 SSCP analyses of p53 exon 7 cDNAs derived from protruding
nodules in rats fed the CDAAE diet (A) or the CDAA diet (B). U, undenatured
product; lanes 1, wild-type sequences (CSAA)
transition (C:T-*C:C, Leu->Pro) at the second base of codon 263;
and a G-*A transition (T:G--T:A, Cys->Tyr) at the second base of
condon 240 (data not shown). These mutations were clearly
different from those observed in the ethionine-treated rats. One of
them (at codon 263) was also different from the point mutations
previously detected in exon 7 of HCCs induced by a methyl-
deficient diet (Smith et al, 1993). Whether these nodules carried
mutations at sites other than codons 226-278 was not determined.
Finally, no deviation from the exon 7 sequence of wild-type p53
was observed in the liver of two CSAA rats [see Figure 3 (WT)
and lanes in Figures 5A and B] and in the liver of rats fed only
laboratory chow (data not shown but see lanes 1 in Figures 4A and
B). All runs of DNA sequencing performed included the negative
and positive controls indicated in the Materials and methods
section. PCR amplification products were not obtained from the
negative controls, while sequencing of the positive controls
confirmed the presence of the known mutations (data not shown).
Therefore, the totality of the results obtained, along with the
methodological approaches used, indicates that no interference
was encountered in this study from the presence in the rat of
processed p53 pseudogenes (Weghorst et al, 1995).
DISCUSSION
Ethionine has been reported to be mutagenic in some fungi but not
in strains of Salmonella typhimurium (Leopold et al, 1982;
Ghoshal et al, 1986). The hepatocarcinogenicity ofthis chemical is
thought to derive from its parasitization of methionine-metabo-
lizing enzymes, as its toxic and carcinogenic effects are prevented
by extra supplies of dietary methionine (Farber, 1963; Ghoshal et
al, 1986; Tsujiuchi et al, 1995). S-adenosylethionine, or possibly
S-vinylhomocysteine, is considered to be the proximate or ulti-
mate carcinogenic metabolite, which could potentially lead to
alkylation of DNA (Farber, 1968; Leopold et al, 1982), even under
conditions of ethionine-induced hepatocarcinogenesis. However,
no indication or information could be found in the literature as to
whether ethionine could lead to ethylation of(5-methyl)cytosine at
CpG sites in DNA. This seems a likely possibility, however, given
that ethionine results in a widespread ethylation of liver rRNA and
tRNA (Farber, 1963, 1968; Ghoshal et al, 1986) and formation of
ethyl analogues of several naturally occurring methyl-containing
metabolites (Ghoshal et al, 1986). The latter include the ethyl
analogue of choline, a fact that may account (McArthur et al,
1947; McArthur and Lucas, 1950) for the mild degree of or
absence of liver steatosis in rats chronically fed ethionine, even
when it is included in a methyl-deficient diet (Shinozuka et al,
1978; Leopold et al, 1982; Tsujiuchi et al, 1995; present study).
In the present study, nodules protruding from the surface of the
liver of male F-344 rats fed ethionine with a methyl-deficient diet
were found to contain point mutations in thep53 gene that have a
pattern quite different from that previously observed in HCCs
induced by a methyl-deficient diet alone (Smith et al, 1993). In the
latter case, the mutations were scattered throughout the 120-290
codon region ofthe gene, while those detected in the ethionine-fed
rats were all present at two hot-spots, codons 246 (a G:C-*A:T
transition) and 247 (a G:C-*T:A transversion). Moreover, the
mutations appeared to be specific to ethionine, at least to the extent
that mutations at these codons were not observed in nodules
(present study) and HCCs (Smith et al, 1993) induced by a methyl-
deficient diet alone. G:C-*A:T transitions and G:C-*T:A transver-
sions are among the most common base substitutions observed in
human tumours, and spontaneous deamination of 5-methylcyto-
sine, if not repaired, is considered to be the most likely source of
the transitions (Greenblatt et al, 1994). G:C--A:T transitions were
previously observed at various sites of the p53 gene of HCCs
induced by a methyl-deficient diet alone (Smith et al, 1993) and
were observed in the present study in ethionine-induced nodules at
codon 246. In both instances, unrepaired deamination of5-methyl-
cytosine could possibly be the source of the transitions, however
this requires further study. Further studies are also required to
determine firstly whether ethionine does indeed result in 5-ethyl-
cytosine at DNA CpG sites and whether the ethylation affects the
rate of deamination of the base and secondly to establish the
genesis of the G:C-*T:A transversion at codon 247. The presence
of mutations at two codons ofthep53 gene have been observed in
cases ofactinic keratosis (Ziegler et al, 1994) and in a human colon
cancer cell line (Rand et al, 1996); in the latter, the mutations were
also on separate alleles. It has been suggested that the spectrum of
p53 gene mutations may provide a fingerprint ofthe DNA changes
caused by environmental carcinogens in humans (Vogelstein and
Kinzler, 1992; Greenblatt et al, 1994). The results of the present
and of a previous study (Vancutsem et al, 1994) seem to support
this concept in the case ofexperimental hepatocarcinogenesis.
In the present study, point mutations were also detected in the
p53 gene ofsome ofthe nodules that developed within 15 weeks in
CDAA rats. This finding again attests the greater efficacy of the
CDAA diet model of methyl-deficiency hepatocarcinogenesis
(Nakae et al, 1990, 1992, 1994), vis-a-vis the choline-deficient diet
model (Lombardi and Smith, 1994). Indeed, in the latter, nodules
usually develop at a much later stage, and 10 months of feeding
was the earliest time at which any evidence of p53 dysfunction
could be observed (Smith et al, 1993). Interestingly, the greater
efficacy ofthe CDAA diet is not accompanied by a marked curtail-
ment in the growth ofthe rats, as is the case with othermethyl-defi-
cient diets (Saito et al, 1994). The mutations observed in rats fed
the CDAA diet, while consistent with previous findings (Smith et
al, 1993), showed no overlap with those present in the ethionine-
treated rats. Therefore, it appears that the hepatocarcinogenic
processes induced by ethionine, and by a methyl-deficient diet
alone, may involve different genomic events, with consequent
selection (for clonal growth) of cells carrying different mutations
in thep53 gene (Hollstein et al, 1991; Greenblatt et al, 1994).
There are, however, other questions left unanswered by the
present study. In only one instance was a single nodule from a
CDAAE rat analysed, and this nodule contained both mutations at
codon 246 and 247. Pools of nodules were used in all other cases
and, even though both mutations were detected in the pools, it
remains to be established whether the two mutations were concur-
rently carried by each individual nodule. In addition, the nature of
the nodules was not examined histologically for the reasons indi-
cated in the Materials and methods section. Here, though, it would
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seem safe to assume that the protruding nodules represented
out-growths ofthose embedded in the liver parenchyma (Figures I
and 2) and were therefore at a similar or at a more advanced
evolution stage (in particular in the larger ones carrying muta-
tions). It may be possible to address the above two questions in
future studies of longer duration if they were to yield adequate
numbers of nodules of a sufficiently large size. As to the mutation
question, an alternate approach may be to analyse the individual
nodules by direct sequencing of DNA rather than sequencing of
cDNAs, as in that case only small amounts ofDNA are required.
In the case of human HCCs, two distinct patterns ofp53 gene
mutations have been observed, depending on the geographical
region of the world (Hollstein et al, 1991; Greenblatt et al, 1994).
In areas in which aflatoxin B, and hepatitis B virus are both risk
factors, the mutations have been found to occur prevalently at
codon 249 of the gene and to consist frequently of G--T transver-
sions, pointing to aflatoxin B, as the most likely causative agent.
On the other hand, in areas where hepatitis B virus but not afla-
toxin B is a risk factor, the mutations have been found to be preva-
lently scattered throughout the gene. Codon 247 of the rat p53
gene corresponds to codon 249 of the human gene, in as much as
they both code for the second of two contiguous arginines (Soussi
et al, 1988). The hepatocarcinogenesis models of a methyl-
deficient diet, with or without addition of ethionine, appear there-
fore to mimic fairly well the two basic patterns ofp53 mutations
observed in human HCCs.
ABBREVIATIONS
AHFs, foci of altered hepatocytes; CDAA, methyl-deficient L-
amino acid defined diet or rats fed the CDAA diet; CDAAE,
CDAA diet containing 0.05% DL-ethionine or rats fed the CDAAE
diet; CSAA, CDAA diet supplemented with choline or rats fed the
CSAA diet; HCCs, hepatocellular carcinomas; PCR, polymerase
chain reaction; PNNs, preneoplastic nodules; RT, reverse tran-
scriptase; SSCP, single-strand conformation polymorphism
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